Utah Code 26B-7-318. Pharmacy reporting requirements
Current as of: 2024 | Check for updates
|
Other versions
(1) Notwithstanding the provisions of Subsection 26B-7-316(1)(a), a pharmacist shall report unusual drug-related events as described in Subsection (2).
Terms Used In Utah Code 26B-7-318
- Bioterrorism: means :(1)(a) the intentional use of any microorganism, virus, infectious substance, or biological product to cause death, disease, or other biological malfunction in a human, an animal, a plant, or another living organism in order to influence, intimidate, or coerce the conduct of government or a civilian population; and(1)(b) includes anthrax, botulism, small pox, plague, tularemia, and viral hemorrhagic fevers. See Utah Code 26B-7-301
- Judgement: The official decision of a court finally determining the respective rights and claims of the parties to a suit.
(2) Unusual drug-related events that require a report include:(2)(a) an unusual increase in the number of prescriptions filled for antimicrobials;(2)(b) any prescription that treats a disease that has bioterrorism potential if that prescription is unusual or in excess of the expected frequency; and(3)(3)(a) A pharmacist shall submit the report required by this section within 24 hours after the pharmacist suspects, in his professional judgement, that an unusual drug-related event has occurred.(4)(4)(a) The report required by this section shall be submitted in accordance with Subsection 26B-7-316(2)(a).(4)(b) A report shall include the name and location of the reporting pharmacist, the name and type of pharmaceuticals that are the subject of the unusual increase in use, and if known, the suspected illness or health condition that is the subject of the report.(5) A pharmacist is subject to the penalties under Subsection 26B-7-316(3) for failing to make a report required by this section.